Rudraiah Swetha, Gu Xinsheng, Hines Ronald N, Manautou José E
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA.
US EPA, National Health and Environmental Effects Research Laboratory, Research Triangle Park, NC, USA.
Toxicol In Vitro. 2016 Mar;31:54-9. doi: 10.1016/j.tiv.2015.11.016. Epub 2015 Nov 23.
The flavin-containing monooxygenases (FMOs) are important for the oxidation of a variety of endogenous compounds and xenobiotics. The hepatic expression of FMO3 is highly variable and until recently, it was thought to be uninducible. In this study, human FMO3 gene regulation by the oxidative stress transcription factor, nuclear factor (erythroid-derived 2)-like 2 (NRF2) was examined. Constitutive FMO3 gene expression is repressed in HepG2 cells, thus this cell can be a good model for FMO3 gene regulation studies. Over-expression of NRF2 in HepG2 cells increased NRF2 target gene expression, heme oxygenase-1 (HMOX1) and
NAD(P)H: quinone oxidoreductase-1 (NQO1), but did not alter FMO3 gene expression. Co-transfection studies with NRF2 or its cytosolic regulatory protein, Kelch-like ECH-associated protein 1 (KEAP1), expression vectors, along with FMO3 promoter luciferase reporter constructs of various lengths (5kb or 6kb), did not change FMO3 reporter gene activity significantly. Furthermore, treatment with tert-butyl hydroperoxide (tBHP) and tert-butyl hydroquinone (tBHQ) did not alter FMO3 reporter construct activity. In summary, in vitro results suggest that the transcriptional regulation of FMO3 might not involve the NRF2-KEAP1 regulatory pathway.
含黄素单加氧酶(FMOs)对于多种内源性化合物和外源性物质的氧化很重要。FMO3的肝脏表达具有高度变异性,直到最近,人们还认为它是不可诱导的。在本研究中,检测了氧化应激转录因子核因子(红系衍生2)样2(NRF2)对人FMO3基因的调控。在HepG2细胞中,FMO3基因的组成型表达受到抑制,因此该细胞可作为FMO3基因调控研究的良好模型。HepG2细胞中NRF2的过表达增加了NRF2靶基因血红素加氧酶-1(HMOX1)和烟酰胺腺嘌呤二核苷酸磷酸(NAD(P)H):醌氧化还原酶-1(NQO1)的表达,但未改变FMO3基因的表达。用NRF2或其胞质调节蛋白kelch样ECH相关蛋白1(KEAP1)表达载体与各种长度(5kb或6kb)的FMO3启动子荧光素酶报告构建体进行共转染研究,并未显著改变FMO3报告基因的活性。此外,用叔丁基过氧化氢(tBHP)和叔丁基对苯二酚(tBHQ)处理也未改变FMO3报告构建体的活性。总之,体外实验结果表明,FMO3的转录调控可能不涉及NRF2-KEAP1调控途径。